Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort study.
Akinfemi AkingboyeFahad MahmoodNabeel AmiruddinMichael ReayPeter NightingaleOlorunseun O OgunwobiPublished in: BMJ open (2021)
Active cancer diagnosis has a threefold increase in risk of hospitalisation with COVID-19. Increased age, urea and CRP predict mortality in patients with cancer. MLA complements traditional statistical analysis in identifying prognostic variables for outcomes of COVID-19 infection in patients with cancer. This study provides proof of concept for MLA in risk prediction for COVID-19 in patients with cancer and should inform a redesign of cancer services to ensure safe delivery of cancer care.
Keyphrases
- coronavirus disease
- papillary thyroid
- sars cov
- squamous cell
- healthcare
- type diabetes
- respiratory syndrome coronavirus
- risk factors
- childhood cancer
- metabolic syndrome
- cardiovascular disease
- mental health
- cardiovascular events
- insulin resistance
- squamous cell carcinoma
- cross sectional
- young adults
- weight loss
- glycemic control
- health insurance